BioPharmSignal logoBioPharmSignal

Biotech News

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

Tactile Systems Technology, Inc. (TCMD)Tactile Systems Technology, Inc.2026-06-25 13:46 ESTConference / presentation

MINNEAPOLIS , Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the presentation of new six-month clinical data during the

Open original release

Related news

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results

View all latest news

Tactile Systems Technology, Inc.

Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.

Recent company news

TCMDTactile Systems Technology, Inc.2026-06-26 08:52 EST

Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

TCMDTactile Systems Technology, Inc.2026-06-26 08:52 EST

Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

TCMDTactile Systems Technology, Inc.2026-06-26 08:52 EST

Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025

TCMDTactile Systems Technology, Inc.2026-06-26 08:52 EST

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

TCMDTactile Systems Technology, Inc.2026-06-26 08:52 EST

Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States